These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21111932)

  • 1. The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment.
    Pilo F; Di Tucci AA; Dessalvi P; Caddori A; Angelucci E
    Eur J Intern Med; 2010 Dec; 21(6):490-5. PubMed ID: 21111932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop.
    Platzbecker U; Santini V; Mufti GJ; Haferlach C; Maciejewski JP; Park S; Solé F; van de Loosdrecht AA; Haase D
    Leuk Res; 2012 Mar; 36(3):264-70. PubMed ID: 22137318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
    Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstöcker M; Rüter B; Sperr WR; Stauder R; Wells DA
    Leuk Res; 2007 Jun; 31(6):727-36. PubMed ID: 17257673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
    Deeg HJ
    Leuk Res; 2004 Jun; 28(6):543-4. PubMed ID: 15120927
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
    Alessandrino EP; Amadori S; Barosi G; Cazzola M; Grossi A; Liberato LN; Locatelli F; Marchetti M; Morra E; Rebulla P; Visani G; Tura S;
    Haematologica; 2002 Dec; 87(12):1286-306. PubMed ID: 12495903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDS researchers seek treatments but find few.
    Bankhead C
    J Natl Cancer Inst; 2007 Jul; 99(13):996-7. PubMed ID: 17596568
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.
    Beran M
    Int J Hematol; 2000 Aug; 72(2):139-50. PubMed ID: 11039661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myelodysplastic syndromes].
    Paladini G; Pecorari P; De Sabbata G; Sammartini C
    Recenti Prog Med; 2004 Feb; 95(2):108-19. PubMed ID: 15072397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving classifications of the myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Opin Hematol; 2007 Mar; 14(2):98-105. PubMed ID: 17255786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome].
    Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany.
    Gattermann N; Hofmann WK; Meessen A; Schmitz S; Tsamaloukas A; Vollmer T; Wedding U; Plesnila-Frank C; Schramm W; Berger K
    Onkologie; 2008 Sep; 31(8-9):477-84. PubMed ID: 18787357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic scoring systems for risk assessment in myelodysplastic syndromes.
    Greenberg PL; Sanz GF; Sanz MA
    Forum (Genova); 1999; 9(1):17-31. PubMed ID: 10101208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the prognosis of patients with myelodysplastic syndromes.
    Aul C; Giagounidis A; Germing U; Ganser A
    Ann Hematol; 2002 Sep; 81(9):485-97. PubMed ID: 12373348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hematologist's approach to myelodysplastic syndrome.
    Fukumoto JS
    Hawaii Med J; 2008 Jun; 67(6):164-6. PubMed ID: 18678209
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
    Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM
    Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.
    Valent P; Horny HP
    Eur J Clin Invest; 2009 Jul; 39(7):548-53. PubMed ID: 19453651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current management of myelodysplastic syndromes].
    Caers J; Bonnet C; Graux C; De Prijck B; Beguin Y
    Rev Med Suisse; 2011 Aug; 7(306):1634, 1636-8, 1640-3. PubMed ID: 21972730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes.
    Aul C; Giagounidis A; Heinsch M; Germing U; Ganser A
    Rev Clin Exp Hematol; 2004 Dec; 8(2):E1. PubMed ID: 16027099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.